Abstract
Purpose
Herein, we detail a promising strategy of nanovesicle preparation based on control of phospholipid self-assembly: the Double Solvent Displacement. A systematic study was conducted and diclofenac as drug model encapsulated. In vitro skin studies were carried out to identify better formulation for dermal/transdermal delivery.
Methods
This method consists in two solvent displacements. The first one, made in a free water environment, has allowed triggering a phospholipid pre-organization. The second one, based on the diffusion into an aqueous phase has led to liposome formation.
Results
Homogeneous liposomes were obtained with a size close to 100 nm and a negative zeta potential around -40 mV. After incorporation of acid diclofenac, we obtained nanoliposomes with a size between 101 ± 45 and 133 ± 66 nm, a zeta potential between 34 ± 2 and 49 ± 3 mV, and the encapsulation efficiency (EE%) was between 58 ± 3 and 87 ± 5%. In vitro permeation studies showed that formulation with higher EE% dispayed the higher transdermal passage (18,4% of the applied dose) especially targeting dermis and beyond.
Conclusions
Our results suggest that our diclofenac loaded lipid vesicles have significant potential as transdermal skin drug delivery system. Here, we produced cost effective lipid nanovesicles in a merely manner according to a process easily transposable to industrial scale.
Similar content being viewed by others
Abbreviations
- CR:
-
Compartment Receptor
- EE%:
-
Encapsulation efficiency
- HPLC:
-
High-performance liquid chromatography
- ISDDS:
-
Innovative skin drug delivery systems
- LNC:
-
Lipid nanocapsules
- MLV:
-
Multilamellar vesicles
- NLC:
-
Nanostructured lipid carriers
- NLS:
-
Solid lipid nanoparticles
- OLV:
-
Oligolamellar vesicles
- PCL:
-
Polycaprolactone
- PCS:
-
Photon correlation spectroscopy
- PDI:
-
Polydispersity Index
- PEG 400:
-
Polyethylene glycol 400
- PLA:
-
Poly (lactic acid)
- PLGA:
-
poly(Lactic-co-glycolic acid)
- rpm:
-
Rotation per minute
- SC:
-
Stratum Corneum
- SD:
-
Standard Deviation
- SEM:
-
Standard Error Mean
- TEM:
-
Transmission electron microscope
- ULV:
-
Unilamellar vesicles
References
Baron JM, Merk HF. Drug metabolism in the skin. Curr Opin Allergy Clin Immunol. 2001;1:287–91.
Afshar M, Gallo RL. Innate immune defense system of the skin. Vet Dermatol. 2013;24:32–e9.
Badri W, Eddabra R, Fessi H, Elaissari A. Biodegradable polymer based nanoparticles: dermal and transdermal drug delivery. J. Colloid Sci. Biotechnol. 2014;3:141–9.
Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J Pharm Pharmacol. 2009;61:1609–16.
Sahoo N, Sahoo RK, Biswas N, Guha A, Kuotsu K. Recent advancement of gelatin nanoparticles in drug and vaccine delivery. Int J Biol Macromol. 2015;81:317–31.
Pamornpathomkul B, Duangjit S, Laohapatarapant S, Rojanarata T, Opanasopit P, Ngawhirunpat T. Transdermal delivery of fluorescein isothiocyanate-dextrans using the combination of microneedles and low-frequency sonophoresis. Asian J Pharm Sci. 2015;10:415–24.
Lira AAM, Cordo PL, Nogueira EC, Almeida EDP, Junior RAL, Nunes RS, et al. Optimization of topical all-trans retinoic acid penetration using poly-DL-lactide and poly-DL-lactide-co-glycolide microparticles. J Colloid Sci Biotechnol. 2013;2:123–9.
Rancan F, Papakostas D, Hadam S, Hackbarth S, Delair T, Primard C, et al. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res. 2009;26:2027–36.
Mondal D, Griffith M, Venkatraman SS. Polycaprolactone-based biomaterials for tissue engineering and drug delivery: current scenario and challenges. Int J Polym Mater Polym Biomater. 2016;65:255–65.
Zhai Y, Zhai G. Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release. 2014;193:90–9.
Pierre MBR. Costa I dos SM. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303:607–21.
Weber J, Funk NL, Motta MH, Guedes AM, Visintainer APC, Tedesco SB, et al. Association of borage oil and betamethasone Dipropionate in lipid-Core Nanocapsules: characterization, Photostability and in vitro irritation test. J Nanosci Nanotechnol. 2016;16:1354–62.
Dasgupta S, Ghosh SK, Ray S, Mazumder B. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation. Curr Drug Deliv. 2013;10:656–66.
Vadlamudi HC, Narendran H, Nagaswaram T, Yaga G, Thanniru J, Yalavarthi PR. Microemulsions based transdermal drug delivery systems. Curr Drug Discov Technol 2014;11:169–180.
Kamble MS, Vaidya KK, Bhosale AV, Nanjwade BK, Shinde SA, Chaudhari PD. Formulation and evaluation of meloxicam nanostructured lipid carrier. J Colloid Sci Biotechnol. 2014;3:167–72.
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1:109–31.
Laouini A, Jaafar-Maalej C, Limayem-Blouza I, Sfar S, Charcosset C, Fessi H. Preparation, characterization and applications of liposomes: state of the art. J Colloid Sci Biotechnol. 2012;1:147–68.
Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin a. J Control Release. 2004;97:55–66.
Gillet A, Compère P, Lecomte F, Hubert P, Ducat E, Evrard B, et al. Liposome surface charge influence on skin penetration behaviour. Int J Pharm. 2011;411:223–31.
Romero EL, Morilla MJ. Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. Int J Nanomedicine. 2013;8:3171–86.
Dragicevic N, Maibach HI, et al. Percutaneous penetration enhancers chemical methods in penetration enhancement. Nanocarriers (Internet). http://link.springer.com/content/pdf/10.1007/978-3-662-47039-8.pdf (2016). Accessed 18 Jan 2017.
Mora-Huertas CE, Garrigues O, Fessi H, Elaissari A. Nanocapsules prepared via nanoprecipitation and emulsification–diffusion methods: comparative study. Eur J Pharm Biopharm. 2012;80:235–9.
Manca ML, Zaru M, Manconi M, Lai F, Valenti D, Sinico C, et al. Glycerosomes: a new tool for effective dermal and transdermal drug delivery. Int J Pharm. 2013;455:66–74.
Sze A, Erickson D, Ren L, Li D. Zeta-potential measurement using the Smoluchowski equation and the slope of the current–time relationship in electroosmotic flow. J Colloid Interface Sci. 2003;261:402–10.
Thong H-Y, Zhai H, Maibach HI. Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol. 2007;20:272–82.
Caddeo C, Manconi M, Sinico C, Valenti D, Celia C, Monduzzi M, et al. Penetration enhancer-containing vesicles: does the penetration enhancer structure affect topical drug delivery? Curr Drug Targets. 2015;16:1438–47.
Manca ML, Castangia I, Matricardi P, Lampis S, Fernàndez-Busquets X, Fadda AM, et al. Molecular arrangements and interconnected bilayer formation induced by alcohol or polyalcohol in phospholipid vesicles. Colloids Surf B Biointerfaces. 2014;117:360–7.
Freeman S, Quillin K, Allison L. Biological science. 5th ed. Boston: Pearson; 2013.
Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28:359–70.
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–IN27.
Phillips MC, Williams RM, Chapman D. On the nature of hydrocarbon chain motions in lipid liquid crystals. Chem Phys Lipids. 1969;3:234–44.
Koynova R, Caffrey M. Phases and phase transitions of the phosphatidylcholines. Biochim Biophys Acta Rev Biomembr. 1998;1376:91–145.
Blok MC, Van Deenen LLM, De Gier J. Effect of the gel to liquid crystalline phase transition on the osmotic behaviour of phosphatidycholine liposomes. Biochim Biophys Acta Biomembr. 1976;433:1–12.
Szoka F Jr, Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng. 1980;9:467–508.
Frézard F, Schettini DA, Rocha OG, Demicheli C. Lipossomas: propriedades físico-químicas e farmacológicas, aplicações na quimioterapia à base de antimônio. Quim Nova. 2005;28:511–8.
Collier JH, Messersmith PB. Phospholipid strategies in biomineralization and biomaterials research. Annu Rev Mater Res. 2001;31:237–63.
Du Plessis J, Egbaria K, Ramachandran C, Weiner N. Topical delivery of liposomally encapsulated gamma-interferon. Antivir Res. 1992;18:259–65.
Lu GW, Valiveti S, Spence J, Zhuang C, Robosky L, Wade K, et al. Comparison of artificial sebum with human and hamster sebum samples. Int J Pharm. 2009;367:37–43.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sala, M., Locher, F., Bonvallet, M. et al. Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery. Pharm Res 34, 1908–1924 (2017). https://doi.org/10.1007/s11095-017-2201-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-017-2201-8